Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK to deliver H1N1 strain to vaccine firms

This article was originally published in Scrip

Executive Summary

The UK's National Institute for Biological Standards and Control (NIBSC) says it has produced a strain of the influenza A/H1N1 virus that is suitable for commercial production of a vaccine. The unit is one of the World Health Organization's collaborating centres (along with those in the US and Australia) that are racing to produce the ideal strain for large-scale production.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts